Abbott Laboratories
Overview
Abbott Laboratories is listed on NYSE and classified as Pharmaceutical Preparations. We have no business description beyond that classification; its SEC filings describe the business.
| Information | Status | As of |
|---|---|---|
| Detailed research report | No report | |
| Rule-based screens | Scored, on no current shortlist | 2026-10-31 |
| Valuation | Model 66.09 (-38% vs price) | 2026-10-31 |
| Chart-pattern read | No read | |
| Paper portfolio | Never held |
Scores
| Method | Score | Inputs as of | Flags |
|---|---|---|---|
| Graham Defensive | 55 | 2025-12-31 | stale input |
| Magic Formula | 32 | 2025-12-31 | stale input |
| Momentum | 47 | 2026-10-30 | |
| Insider | 0 | 2026-10-30 | |
| Buffett Quality | 82 | 2025-12-31 | stale input |
| Lynch GARP | 48 | 2025-12-31 | stale input |
| Graham Enterprising | 50 | 2025-12-31 | stale input |
| Piotroski F-Score | 67 |
Every input with its filing: full score sheet · research packet (JSON) · Markdown · SEC filings.
Valuation
66.09 -38% vs price
Range 49.72 to 94.52, 3 of 3 methods agree. A labelled model estimate, not a price target. Method.